Macrophage migration inhibitory factor: Identification of the 30-kDa MIF-related protein in bovine brain

Neurochemical Research

Volumn 29, Issue 7, 2004, Pages 1399-1404

  Cherepkova, O A ^a   Gurvits, B Ya ^a  

^a BACH INSTITUTE OF BIOCHEMISTRY   (Russian Federation)

Author keywords

Bovine brain; Macrophage migration inhibitory factor; P hydroxyphenylpyruvate tautomerase; Primary structure

Indexed keywords

4 HYDROXYPHENYLPYRUVIC ACID; ANTIBODY; CELL EXTRACT; MACROPHAGE MIGRATION INHIBITION FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR ANTIBODY; PROTEIN; PYRUVIC ACID DERIVATIVE; TAUTOMERASE; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BRAIN; CATTLE; CELL; CONTROLLED STUDY; CYTOSOL; DATA BASE; ENZYME ACTIVITY; ION EXCHANGE CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN MODIFICATION; PROTEIN PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE ANALYSIS; TISSUE; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; BRAIN LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR GENETICS;

ANIMALIA; BOS TAURUS; BOVINAE;

AMINO ACID SEQUENCE; ANIMALS; BRAIN CHEMISTRY; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS;

EID: 3442897937     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000026403.06238.73     Document Type: Article

References (34)

1. Bloom, B. R. and Bennet, B. 1966. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 153:80-82.
2. David, J. R. 1966. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56:72-77.
3. Galat, A., Riviere, S., and Bouet, F. 1993. Purification of macrophage migration inhibitory factor (MIF) from bovine brain cytosol. FEBS Lett. 319:233-236.
4. Galat, A., Riviere, S., Bouet, F., and Menez, A. 1994. A diversified family of 12-kDa proteins with a high amino acid sequence similarity to macrophage migration-inhibitory factor (MIF). Eur. J. Biochem. 224:417-121.
5. Nishino, T., Bernhagen, J., Shiiki, H., Calandra, T., Dohi, K., and Bucala, R. 1995. Localization of MIF in secretory granules within the corticotropic thyrotropic cells of the pituitary gland. Mol. Med. 1:781-788.
6. Donnelly, S. C. and Bucala, R. 1997. Macrophage migration inhibitory factor: A regulator of glucocorticoid activity with a critical role in inflammatory disease. Mol. Med. Today. 3(11):502-507.
7. Baugh, J. A. and Bucala, R. 2002. Macrophage migration inhibitory factor. Crit. Care Med. 30:S27-S35.
8. Baugh, J. A. and Donnely, S. C. 2003. Macrophage migration inhibitory factor: A neuroendocrine modulator of chronic inflammation. J. Endocrinol. 179:15-23.
9. Calandra, T., Bernhagen, J., Mitchell, R., and Bucala, R. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179:1895-1902.
10. Rossi, A. G., Haslett, C., Hirani, N., Greenberg, A. P., Rahman, I., Metz, C. N., Bucala, R., and Donnelly, S. C. 1998. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). J. Clin. Invest. 101:2869-2874.
11. Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., and Bucala, R. 1993. Macrophage migration inhibitory factor (MIF) is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756-759.
12. Bucala, R. 1998. Neuroimmunomodulation by macrophage migration inhibitory factor (MIF). Ann. N. Y. Acad. Sci. 840:74-82.
13. Fingerle-Rowson, G. R. and Bucala, R. 2001. Neuroendocrine properties of macrophage migration inhibitory factor (MIF). Immunol. Cell Biol. 79(4):368-375.
14. Bacher, M., Meinhardt, A., Lan, H. Y., Dhabhar, F. S., Mu, W., Metz, C. N., Chesney, J. A., Gemsa, D., Donnelly, T., Atkins, R. C., and Bucala, R. 1998. MIF expression in the rat brain: Implications for neuronal function. Mol. Med. 4(4):217-230.
15. Nishihira, J. and Ogata, A. 2001. Macrophage migration inhibitory factor as a target molecule in multiple sclerosis. Curr. Opin. Investig. Drugs 2(6):778-782.
16. Nishio, Y., Minami, A., Kato, H., Kaneda, K., and Nishihira, J. 1999. Identification of macrophage migration inhibitory factor (MIF) in rat peripheral nerves: Its possible involvement in nerve regeneration. Biochim. Biophys. Acta 1453(1):74-82.
17. Bacher, M., Weihe, E., Dietzschold, B., Meinhardt, A., Vedder, H., Gemsa, D., and Bette, M. 2002. Borna disease virus-induced accumulation of macrophage migration inhibitory factor in rat brain astrocytes is associated with inhibition of macrophage infiltration. Glia 37(4):291-306.
18. Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., and Beach, D. H. 1999. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 190:1375-1382.
19. Bendrat, K., Al-Abed, Y., Callaway, D. J., Peng, T., Calandra, T., Metz, C. N., and Bucala, R. 1997. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry 36:15356-15362.
20. Rosengren, E., Aman, P., Thelin, S., Haussen, C., Ahlfors, S., Bjork, P., Jacobsson, L., and Rorsman, H. 1997. The macrophage migration inhibitory factor (MIF) is a phenylpyruvate tautomerase. FEBS Lett. 417:85-88.
21. Kleemann, R., Kapurniotu, A., Frank, R. W., Gessner, A., Mischke, R., Flieger, O., Juttner S., Brunner H., and Bernhagen J. 1998. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protern oxidoreductase. J. Mol. Biol. 280:85-102.
22. Rosengren, E., Bucala, R., Eman, P., Jacobsson, L., Odh, G., Metz, C. N., and Rorsman, H. 1996. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol. Med. 2:143-149.
23. Galoyan, A. A., Gurvits, B. Ya., Shuvalova, L. A., Davis, M. T., Shively, J. E., and Lee, T. D. 1992. A hypothalamic activator of calmodulin-dependent enzymes is thymosin beta 4 (1-39). Neurochem. Res. 17:773-777.
24. Gurvits, B. Ya. and Galoyan, A. A. 1995. Structure and function of immunophilin, a receptor of immunosuppressor FK506, isolated from bovine hypothalamus. J. Neurochem. 65(Suppl):S178.
25. Gurvits, B. Ya., Egorov, Ts. A., and Galoyan, A. A. 1997. Identification of parvalbumin alpha in bovine hypothalamus: A partial primary structure. Neurochem. Res. 22:799-803.
26. Gurvits, B. Ya., Tretyakov O. Yu., Klishina, N. V., Stoeva, S., Voelter, W., and Galoyan, A. A. 2000. Identification of macrophage migration inhibitory factor isoforms in bovine brain. Neurochem. Res. 25:1125-1129.
27. Bernhagen, J., Mitchell, R. A., Calandra, T., Voelter, W., Cerami, A., and Bucala, R. 1994. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33(47):14144-14155.
28. Knox, W. E. and Pitt, B. M. 1957. Enzymatic catalysis of the keto-enol tautomerization of phenylpyruvic acids. J. Biol. Chem. 225:675-688.
29. Swope, M., Sun, H-W., Blake, P. R., and Lolis, E. 1998. Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor. EMBO J. 17:3534-3541.
30. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
31. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
32. Mischke, R., Kleemann, R., Brunner, H., and Bernhagen, J. 1998. Cross-linking and mutational analysis of the oligomerization state of the cytokine macrophage migration inhibitory factor (MIF). FEBS Lett. 427:85-90.
33. Nguyen, M. T., Beck, J., Lue, H., Funfzig, H., Kleemann, R., Koolwijk, P., Kapumiotu, A., and Bernhagen, I. 2003. A 16-residue peptide fragment of macrophage migration inhibitory factor, MIF-(50-65), exhibits redox activity and has MIF-like biological functions. J. Biol. Chem. 278:33654-33671.
34. Lubetsky, J. B., Dios, A., Han, J., Aljabari, B., Ruzsicska, B., Mitchell, R., Lolis, E., and Al Abed, Y. 2002. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J. Biol. Chem. 277:24976-24982.